Measurement of Autoantibodies in Pediatric-Onset Systemic Lupus Erythematosus and Their Relationship with Disease-Associated Manifestations

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 6, 2012, Pages 840-848

  Gilliam, Brooke E ^a   Ombrello, Amanda K ^a,c   Burlingame, Rufus W ^b   Pepmueller, Peri H ^a   Moore, Terry L ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INOVA DIAGNOSTICS INC   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Anti C1q antibodies; Anti double stranded DNA antibodies; Nephritis; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CHROMATIN ANTIBODY; COMPLEMENT; COMPLEMENT COMPONENT C1Q ANTIBODY; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; HIGH AVIDITY DOUBLE STRANDED DNA ANTIBODY; HISTONE ANTIBODY; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RIBOSOMAL P ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOLYTIC ANEMIA; HUMAN; KIDNEY DISEASE; LABORATORY TEST; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL RECORD REVIEW; NEPHRITIS; ONSET AGE; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY CAST;

ADOLESCENT; ADULT; AUTOANTIBODIES; CHILD; COMPLEMENT C1Q; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEVERITY OF ILLNESS INDEX;

EID: 84861222651     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.09.009     Document Type: Article

References (46)

1. Font J., Cervera R., Espinosa G., Pallarés L., Ramos-Casals M., Jiménez S., et al. Systemic lupus erythematosus in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998, 57:456-459.
2. Klein-Gitelman M., Reiff A., Silverman E.D. Systemic lupus erythematosus in childhood. Rheum Dis Clin North Am 2002, 28:561-577.
3. Brunner H.I., Gladman D.D., Ibanez D., Urowitz M.D., Silverman E.D. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008, 58:556-562.
4. Kamphuis S., Silverman E.D. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol 2010, 6:538-546.
5. Campos L.M., Kiss M.H., Scheinberg M.A., Mangueira C.L., Silva C.A. Antinucleosome antibodies in patients with juvenile systemic lupus erythematosus. Lupus 2006, 15(8):496-500.
6. Isenberg D. Anti-dsDNA antibodies: still a useful criterion for patients with systemic lupus erythematosus. Lupus 2004, 13:881-885.
7. Hoffman I.E., Lauwerys B.R., De Keyser F., Huizinga T.W., Isenberg D., Cebecauer L., et al. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis 2009, 68:412-415.
8. Feng J.B., Ni J.D., Yao X., Pan H.F., Li X.P., Xu J.H., et al. Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1790 cases. Rheumatol Int 2010, 30:1017-1023.
9. McCurdy D.K., Lehman T.J., Bernstein B., Hanson V., King K.K., Nadorra R., et al. Lupus nephritis: prognostic factors in children. Pediatrics 1992, 89:240-246.
10. Eggert M., Zettl U.K., Neeck G. Autoantibodies in autoimmune diseases. Curr Pharm Des 2010, 16:1634-1643.
11. Sherer Y., Gorstein A., Fritzler M.J., Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004, 34:501-537.
12. Wu F.Q., Zhao Q., Cui X.D., Zhang W. C1q and anti-C1q antibody levels are correlated with disease severity in Chinese pediatric systemic lupus erythematosus. Rheumatol Int 2011, 31:501-505.
13. Muscal E., Bloom D.R., Hunter J.V., Myones B.L. Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution. Lupus 2010, 19:268-279.
14. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
15. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997, 40:1725.
16. Gladman D.D., Ibanez D., Urowitz M.B. Systemic lupus erythematosus disease activity idex 2000. J Rheumatol 2002, 29:288-291.
17. Yee C.S., Farewell V.T., Isenberg D.A., Griffiths B., Teh L.S., Bruce I.N., et al. The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. Rheumatology 2011, 50:982-988.
18. Gladman D.D., Urowitz M.B., Kagal A., Hallett D. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol 2000, 27:377-379.
19. Cai X., Yang X., Lian F., Lin X., Liang M., Li J., et al. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis. J Rheumatol 2010, 37:759-765.
20. Pickering M.C., Botto M. Are anti-C1q antibodies different from other SLE autoantibodies?. Nat Rev Rheumatol 2010, 6:490-493.
21. Seelen M.A., Trouw L.A., Daha M.R. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus. Curr Opin Nephrol Hypertens 2003, 12:619-624.
22. Marto N., Bertolaccini M.L., Calabuig E., Hughes G.R., Khamashta M.A. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 2005, 64:444-448.
23. Jesus A.A., Silva C.A., Carneiro-Sampaio M., Sheinberg M., Mangueira C.L., Marie S.K., et al. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus. Ann NY Acad Sci 2009, 1173:235-238.
24. Kozyro I., Perahud I., Sadallah S., Sukalo A., Titov L., Schifferli J., et al. Clinical value of autoantibodies against C1q in children with glomerulonephritis. Pediatrics 2006, 117(5):1663-1668.
25. Siegert C.E., Daha M.R., Tseng C.M., Coremans I.E., van Es L.A., Breedveld F.C. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis 1993, 52(12):851-856.
26. Coremans I.E., Spronk P.E., Bootsma H., Daha M.R., van der Voort E.A., Kater L., et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 1995, 26(4):595-601.
27. Ermann J., Bermas B.L. The biology behind the new therapies for SLE. Int J Clin Pract 2007, 61:2113-2119.
28. Kamat S.S., Pepmueller P.H., Moore T.L. Triplets with systemic lupus erythematosus. Arthritis Rheum 2003, 48:3176-3180.
29. Fiegel F., Buhl A., Jaekel H.-P., Werle E., Schmolke M., Ollert M., et al. Autoantibodies to double-stranded DNA-Intermethod comparison between four commercial immunoassays and a research biosensor-based device. Lupus 2010, 19:957-964.
30. Isenberg D., Smeenk R. Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now?. Lupus 2002, 11:797-800.
31. Launay D., Schmidt J., Lepers S., Mirault T., Lambert M., Kyndt X., et al. Comparison of the Farr radioimmunoassay, 3 commercial enzyme linked immunoassays and Crithidia Luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus. Clin Chim Acta 2010, 411:959-964.
32. Hanly J.G., Su L., Farewell V., Fritzler M.J. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. J Immunol Methods 2010, 358:75-80.
33. Antico A., Platzgummer S., Bassetti D., Bizzaro N., Tozzoli R., Villalta D., et al. Diagnosing systemic lupus erythematosus: new- generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia Luciliae immunofluorescence test. Lupus 2010, 19:906-912.
34. Riboldi P., Gerosa M., Moroni G., Radice A., Allegri F., Sinico A., et al. Anti-dsDNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?. Autoimmunity 2005, 38:39-45.
35. Gómez-Puerta J.A., Burlingame R.W., Cervera R. Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value. Autoimmun Rev 2008, 7(8):606-611.
36. Heidenreich U., Mayer G., Herold M., Klotz W., Stempfl Al-Jazrawi K., Lhotta K. Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis. Lupus 2009, 18(14):1276-1280.
37. Shabana A.A., El-Ghawet A.E., Machaly S.A., Abu Hashim E.M., El-Kady B.A., Shaat R. Anti-chromatin and anti-histone antibodies in Egyptian patients with systemic lupus erythematosus. Clin Rheumatol 2009, 28(6):673-678.
38. Souza A., da Silva L.M., Oliveira F.R., Roselino A.M., Louzada-Junior P. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease. Lupus 2009, 18(3):223-229.
39. Sun X.Y., Shi J., Han L., Su Y., Li Z.G. Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus. J Clin Lab Anal 2008, 22(4):271-277.
40. Cohen M.G., Pollard K.M., Webb J. Antibodies to histones in systemic lupus erythematosus: prevalence, specificity, and relationship to clinical and laboratory features. Ann Rheum Dis 1992, 51(1):61-66.
41. Gompertz N.R., Isenberg D.A., Turner B.M. Correlation between clinical features of systemic lupus erythematosus and levels of antihistone antibodies of the IgG, IgA, and IgM isotypes. Ann Rheum Dis 1990, 49(7):524-527.
42. Yung R.L., Quddus J., Chrisp C.E., Johnson K.J., Richardson B.C. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 1995, 154(6):3025-3035.
43. Efthimiou P., Blanco M. Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers. Mod Rheumatol 2009, 19:457-468.
44. Ghirardello A., Briani C., Lucchetta M., Doria A. Anti-ribosomal P protein antibodies and neuropsychiatric systemic lupus erythematosus: cross-sectional vs. prospective studies. Lupus 2010, 19:771-773.
45. Haddouk S., Marzouk S., Jallouli M., Fourati H., Frigui M., Hmida Y.B., et al. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus. Rheumatology 2009, 48:953-957.
46. Hanly J.G., Urowitz M.B., Siannis F., Farewell V., Gordon C., Bae S.C., et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 2008, 58:843-853.